Growth Hormone Deficiency Market Size, Share and Forecast 2026
In January 2019, the European Medicines Agency granted marketing approval to Aeterna Zentaris Inc.'s macimorelin for the diagnosis of adult growth hormone deficiency.
(EMAILWIRE.COM, September 09, 2019 ) Market Overview:
Growth Hormone Deficiency (GHD) is a rare endocrine disorder that occurs due to impaired secretion of somatropin, a peptide growth hormone (GH) from the pituitary gland which is responsible for the growth and cell reproduction.
The Growth Hormone Deficiency market was worth $XX million in 2018 and is forecasted to reach $XX million by 2026, at a CAGR of XX% during the forecast period.
Market Dynamics:
The market is driven by an increase in the incidences of GHD, the introduction of technologically advanced drugs with improved patient compliance and increased awareness of the disease. The high cost of treatment for GHD is the only reason that is expected to restrain the market growth over the period of forecast.
Market Segmentation:
By treatment type as:
• Surgery
• Growth Hormone Therapy
By the end user as:
• Hospitals
• Clinics
• Homecare settings
By distribution channels as:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
Geographical Analysis:
Geographically, the Growth Hormone Deficiency market is divided into:
• North America
• Europe
• South America
• Asia-Pacific
• The Middle East and Africa
Competitive Analysis:
Key Players:
• Sandoz International GmbH
• Sanofi-Aventis
• Pfizer
• Novo Nordisk A/S
• Teva Pharmaceutical Industries Limited
• Ranbaxy
View full report: https://www.datamintelligence.com/research-report/growth-hormone-deficiency-market
Download free sample: https://www.datamintelligence.com/download-sample/growth-hormone-deficiency-market
About Us
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Growth Hormone Deficiency (GHD) is a rare endocrine disorder that occurs due to impaired secretion of somatropin, a peptide growth hormone (GH) from the pituitary gland which is responsible for the growth and cell reproduction.
The Growth Hormone Deficiency market was worth $XX million in 2018 and is forecasted to reach $XX million by 2026, at a CAGR of XX% during the forecast period.
Market Dynamics:
The market is driven by an increase in the incidences of GHD, the introduction of technologically advanced drugs with improved patient compliance and increased awareness of the disease. The high cost of treatment for GHD is the only reason that is expected to restrain the market growth over the period of forecast.
Market Segmentation:
By treatment type as:
• Surgery
• Growth Hormone Therapy
By the end user as:
• Hospitals
• Clinics
• Homecare settings
By distribution channels as:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
Geographical Analysis:
Geographically, the Growth Hormone Deficiency market is divided into:
• North America
• Europe
• South America
• Asia-Pacific
• The Middle East and Africa
Competitive Analysis:
Key Players:
• Sandoz International GmbH
• Sanofi-Aventis
• Pfizer
• Novo Nordisk A/S
• Teva Pharmaceutical Industries Limited
• Ranbaxy
View full report: https://www.datamintelligence.com/research-report/growth-hormone-deficiency-market
Download free sample: https://www.datamintelligence.com/download-sample/growth-hormone-deficiency-market
About Us
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Contact Information:
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results